Literature DB >> 11068198

Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims.

P Rosel1, B Arranz, L San, J Vallejo, J M Crespo, M Urretavizcaya, M A Navarro.   

Abstract

The binding parameters of 5-HT(2A) and levels of its second messenger, 1,4,5-trisphosphate (IP(3)), were simultaneously studied in frontal cortex and hippocampus from the brains of 18 control subjects and 18 depressed suicide victims. All suicides met DSM-III-R criteria for depressive symptoms, suffered a violent death and had not taken any antidepressant drugs for at least 6 months prior to death. A significant decrease in the number of 5-HT(2A) binding sites (154+/-22 vs. 254+/-36 fmol/mg), together with a significantly lower apparent affinity constant (1.02+/- 0.08 vs. 1. 36+/-0.09 nM), was detected in hippocampus but not in frontal cortex from the depressed suicides compared to the control subjects. Furthermore, IP(3) concentrations were significantly increased in hippocampus (3.2+/-0.3 vs. 2.1+/-0.3 pmol/g) but not in frontal cortex (1.3+/-0.3 vs. 2.7+/-0.5 pmol/g) from the suicide victims. The reported results may indicate a significant hypersensitivity of the 5-HT(2A) postsynaptic receptor located in the hippocampus from depressed suicide victims, giving rise to an enhancement of its intracellular signaling system with higher IP(3) production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11068198     DOI: 10.1016/s0925-4927(00)00076-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  18 in total

1.  Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.

Authors:  Jie Xu; Bo Jian; Richard Chu; Zhibin Lu; Quanyi Li; John Dunlop; Sharon Rosenzweig-Lipson; Paul McGonigle; Robert J Levy; Bruce Liang
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  The interpersonal theory of suicide.

Authors:  Kimberly A Van Orden; Tracy K Witte; Kelly C Cukrowicz; Scott R Braithwaite; Edward A Selby; Thomas E Joiner
Journal:  Psychol Rev       Date:  2010-04       Impact factor: 8.934

Review 3.  Stress, genes and the biology of suicidal behavior.

Authors:  Dianne Currier; J John Mann
Journal:  Psychiatr Clin North Am       Date:  2008-06

4.  Gender, personality, and serotonin-2A receptor binding in healthy subjects.

Authors:  Paul H Soloff; Julie C Price; Neale Scott Mason; Carl Becker; Carolyn C Meltzer
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

5.  What can post-mortem studies tell us about the pathoetiology of suicide?

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi
Journal:  Future Neurol       Date:  2010-09

Review 6.  Suicides in the military: the post-modern combat veteran and the Hemingway effect.

Authors:  Carl Andrew Castro; Sara Kintzle
Journal:  Curr Psychiatry Rep       Date:  2014-08       Impact factor: 5.285

7.  Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.

Authors:  F Pilar-Cuéllar; R Vidal; A Pazos
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 8.  Biological basis of suicide and suicidal behavior.

Authors:  Ghanshyam N Pandey
Journal:  Bipolar Disord       Date:  2013-06-15       Impact factor: 6.744

9.  Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects.

Authors:  Hymie Anisman; Lisheng Du; Mikos Palkovits; Gabor Faludi; Gabor G Kovacs; Peter Szontagh-Kishazi; Zul Merali; Michael O Poulter
Journal:  J Psychiatry Neurosci       Date:  2008-03       Impact factor: 6.186

Review 10.  Regulating prefrontal cortex activation: an emerging role for the 5-HT₂A serotonin receptor in the modulation of emotion-based actions?

Authors:  Susana Aznar; Anders B Klein
Journal:  Mol Neurobiol       Date:  2013-05-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.